Search

Displaying results 6101 - 6110 of 8696 in total

Drug
Tavilermide
go.drugbank.com/drugs/DB12441
Investigational
Tavilermide has been investigated for the treatment of Dry Eye Syndromes.
Drug
Fosbretabulin
go.drugbank.com/drugs/DB12577
Investigational
Fosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer.
Drug
Felzartamab
go.drugbank.com/drugs/DB16375
Investigational
Felzartamab is under investigation in clinical trial NCT04145440 (Trial to Assess Safety and Efficacy of MOR202 in Anti-pla2r + Membranous Nephropathy (Amn)).
Drug
Nicotinyl alcohol
go.drugbank.com/drugs/DB04145
Experimental
A direct-acting peripheral vasodilator that causes flushing and may decrease blood pressure. It is used in vasospasm and threatened gangrene. [PubChem]
Drug
Bleomycin A6
go.drugbank.com/drugs/DB12992
Investigational
It was developed in China as an antineoplastic antibiotic. This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer.
Drug
Sulfachlorpyridazine
go.drugbank.com/drugs/DB11461
ExperimentalVet approved
A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.
Drug
Ataciguat
go.drugbank.com/drugs/DB12805
Investigational
Ataciguat has been investigated for the basic science of Aortic Valve Stenosis.
Drug
Naftopidil
go.drugbank.com/drugs/DB12092
Investigational
Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
MK-0557
go.drugbank.com/drugs/DB12168
Investigational
MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.
Drug
BMS-863233
go.drugbank.com/drugs/DB12357
Investigational
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.